Journal article
Hepatocellular carcinoma: options for diagnosing and managing a deadly disease
Cleveland Clinic journal of medicine, Vol.80(10), pp.645-653
10/2013
DOI: 10.3949/ccjm.80a.12163
PMID: 24085810
Abstract
Hepatocellular carcinoma (HCC) is an important cause of death in patients with liver disease, and its incidence appears to be rising in the United States. Because early diagnosis improves the chances of survival, it is important to identify patients who would benefit from surveillance. Once HCC is suspected on surveillance, noninvasive diagnostic tests are available to make an accurate diagnosis. Treatment should be individualized, based on the characteristics of the tumor and the degree of liver dysfunction.
Details
- Title: Subtitle
- Hepatocellular carcinoma: options for diagnosing and managing a deadly disease
- Creators
- Arvind R Murali - Department of Internal Medicine, John H. Stroger Jr. Hospital of Cook County, Chicago, ILCarlos Romero-MarreroFederico AucejoK V Narayanan Menon
- Resource Type
- Journal article
- Publication Details
- Cleveland Clinic journal of medicine, Vol.80(10), pp.645-653
- DOI
- 10.3949/ccjm.80a.12163
- PMID
- 24085810
- NLM abbreviation
- Cleve Clin J Med
- ISSN
- 0891-1150
- eISSN
- 1939-2869
- Language
- English
- Date published
- 10/2013
- Academic Unit
- Gastroenterology and Hepatology; Internal Medicine
- Record Identifier
- 9984094406102771
Metrics
28 Record Views